U.S. Biotech Partner Obtains Marketing Authorization for ADHD Treatment in Taiwan
September 18, 2018 at 04:00 AM EDT
Source: Streetwise Reports 09/18/2018 Permission has been obtained to distribute time-release capsules. DURECT Corp. announced that Orient Pharma Co., Ltd., its licensee for certain Asian and South Pacific countries, has informed DURECT that it has [...]
